Who can we trust? At first, it was the elevated amounts of lead found in a cooking product that made us question our relation with industrially manufactured food but now, apparently, the pharmaceutical industry is incautiously producing questionable medicines and despite the health risk, giving it their stamp of approval. As it happens, Pfizer is in trouble with the FDA again.

How can something like medication be handled so carelessly? Recently, Hospira, a part of the pharmaceutical giants, Pfizer, recalled a particular lot of 0.25% bupivacaine hydrochloride injection, USP (NDC: 0409-1159-02, Lot 59-064- DK, Expiry 1NOV2017) due to the presence of a dangerous particulate matter. Bupivacaine hydrochloride injection is a local anesthetic used in dental and oral surgery along with diagnostic and therapeutic procedures.

After a complaint was launched against the particular injection, Hospira warned the local population about the possible harm that can come from the administration of this product. If the particulate were to be given to a patient, there would have been a high probability that they might experience swelling, irritation of blood vessels or tissue, blockage blood vessels and even allergic reactions.

This isn’t the first time these New York drug giants, such as Pfizer, have landed themselves in trouble with the FDA. According to FiercePharma, Pfizer was forced to suspend their production of sterile drugs at their Hospira Indian plant after FDA issued a warning letter highlighting the unhygienic conditions. Back in February 2016, Pfizer recalled certain lots of Advil pediatric drops along with children’s Advil oral suspension products due to clumps that formed in the bottle resulting in inconsistent dosages if not shaken properly.

Although no legitimate complaint has been registered so far but if such inconsistencies continue to occur, the FDA may be forced to shut this company down in order to investigate the reasons behind these mix-ups.